cGMP
cGMP 相关产品(26)
- GC40231Milrinone-d3CAS: 2749393-50-6纯度: >99.00%
An internal standard for the quantification of milrinone
- GC424604-Nitrophenyl PhenylphosphonateCAS: 57072-35-2纯度: >98.00%
A 5′-nucleotide phosphodiesterase substrate
- GC47088Cilostazol-d4CAS: 1215541-47-1纯度: >99.00%
An internal standard for the quantification of cilostazol
- GC47237Dipyridamole-d16CAS: 2712261-50-0纯度: >99.00%
A neuropeptide with diverse biological activities
- GC47923Paraxanthine-d6CAS: 117490-41-2纯度: >99.00%
An internal standard for the quantification of paraxanthine
- GC48078Sildenafil-d3CAS: 1126745-90-1纯度: >99.50%
An internal standard for the quantification of sildenafil
- GC48121Tadalafil-d3CAS: 960226-55-5纯度: >99.00%
An internal standard for the quantification of tadalafil
- GC48243Vardenafil-d5CAS: 1189685-70-8纯度: >99.00%
An internal standard for the quantification of vardenafil
- GC4903615-(6-nitroxyhexanoyl)-17-phenyl trinor Prostaglandin F2αCAS: 1194396-71-8纯度: >98.00%
A nitric oxide-donating derivative of 17-phenyl trinor prostaglandin F 2α
- GC49086Nicorandil-d4CAS: 1132681-23-2纯度: >99.00%
An internal standard for the quantification of nicorandil
- GC49358Sildenafil ChlorosulfonylCAS: 139756-22-2纯度: >98.00%
An intermediate in the synthesis of sildenafil
- GC49683N-desethyl-N-methyl VardenafilCAS: 224785-87-9纯度: >95.00%
A potential impurity found in commercial preparations of vardenafil
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC10005 | SEP-0372814 | 1516895-53-6 | - | |
A PDE10A inhibitor | ||||
| GC18951 | Obscurolide A1 | 144397-99-9 | - | |
A phosphodiesterase inhibitor | ||||
| GC40231 | Milrinone-d3 | 2749393-50-6 | >99.00% | |
An internal standard for the quantification of milrinone | ||||
| GC42460 | 4-Nitrophenyl Phenylphosphonate | 57072-35-2 | >98.00% | |
A 5′-nucleotide phosphodiesterase substrate | ||||
| GC42625 | 8-DY547-cGMP | - | >98.00% | |
通过结合环核苷酸激活，环核苷酸门控 (CNG) 离子通道介导光感受器和嗅觉细胞中的感觉信号转导。 | ||||
| GC43341 | Cyclic GMP | 40732-48-7 | >98.00% | |
A second messenger | ||||
| GC44350 | N-Desmethyl Sildenafil | 139755-82-1 | >98.00% | |
A major metabolite of sildenafil | ||||
| GC44351 | N-Desmethyl Sildenafil (citrate) | - | >98.00% | |
A major metabolite of sildenafil | ||||
| GC44673 | PQ-10 | 927691-21-2 | >98.00% | |
A selective PDE10 inhibitor | ||||
| GC46898 | Avanafil-13C-d3 | 2738376-89-9 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47088 | Cilostazol-d4 | 1215541-47-1 | >99.00% | |
An internal standard for the quantification of cilostazol | ||||
| GC47237 | Dipyridamole-d16 | 2712261-50-0 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47923 | Paraxanthine-d6 | 117490-41-2 | >99.00% | |
An internal standard for the quantification of paraxanthine | ||||
| GC48078 | Sildenafil-d3 | 1126745-90-1 | >99.50% | |
An internal standard for the quantification of sildenafil | ||||
| GC48121 | Tadalafil-d3 | 960226-55-5 | >99.00% | |
An internal standard for the quantification of tadalafil | ||||
| GC48243 | Vardenafil-d5 | 1189685-70-8 | >99.00% | |
An internal standard for the quantification of vardenafil | ||||
| GC48870 | Anagrelide-13C3 | - | >98.00% | |
An internal standard for the quantification of anagrelide | ||||
| GC49036 | 15-(6-nitroxyhexanoyl)-17-phenyl trinor Prostaglandin F2α | 1194396-71-8 | >98.00% | |
A nitric oxide-donating derivative of 17-phenyl trinor prostaglandin F 2α | ||||
| GC49086 | Nicorandil-d4 | 1132681-23-2 | >99.00% | |
An internal standard for the quantification of nicorandil | ||||
| GC49349 | O-Desethyl Sildenafil | 139755-91-2 | >95.00% | |
A metabolite of sildenafil | ||||
| GC49358 | Sildenafil Chlorosulfonyl | 139756-22-2 | >98.00% | |
An intermediate in the synthesis of sildenafil | ||||
| GC49511 | Nicorandil N-oxide | 107833-98-7 | >98.00% | |
A metabolite of nicorandil | ||||
| GC49683 | N-desethyl-N-methyl Vardenafil | 224785-87-9 | >95.00% | |
A potential impurity found in commercial preparations of vardenafil | ||||
| GC90924 | TNP-GTP (sodium salt) | - | >95.00% | |
一种荧光标记的GTP衍生物 | ||||